Wells Fargo Downgrades Team Health (TMH) to Market Perform
- Wall Street falls ahead of inauguration
- IBM (IBM) Tops Q4 EPS by 13c, FY17 EPS Guidance Beats Consensus
- American Express (AXP) Misses Q4 EPS by 7c, FY17 EPS Guidance Tops Views at Mid-Poinit
- Skyworks Solutions (SWKS) Tops Q1 EPS by 3c, Offers Q2 Guidance, Announces Buyback
- Synergy Pharma (SGYP) Trulance (Plecanatide) Approved by FDA
Get the Pulse of the Market with StreetInsider.com's Pulse Picks. Get your Free Trial here.
Wells Fargo downgraded Team Health (NYSE: TMH) from Outperform to Market Perform.
Shares of Team Health closed at $36.80 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- UPDATE: Wells Fargo Downgrades Goldman Sachs BDC, Inc. (GSBD) to Market Perform Citing Valution
- Standpoint Research Downgrades United Therapeutics Corp. (UTHR) to Hold
- Goldman Sachs Downgrades Vitamin Shoppe (VSI) to Sell
Create E-mail Alert Related CategoriesDowngrades
Related EntitiesWells Fargo
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!